Synthesis and evaluation of 99mTc(CO)3-DTPA-folate as a folate-receptor-targeted radiopharmaceutical

David P. Trump, Carla J. Mathias, Zhenfan Yang, Philip S. Low, Mary Marmion, Mark Green

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

A folate-receptor-targeted 99mTc-radiopharmaceutical, [99mTc]Tc(CO)3DTPA-folate, was prepared by heating [99mTc]Tc(CO)3(H2O)3+ in an aqueous solution of the previously reported DTPA-folate conjugate. The radiotracer was HPLC purified (> 98% radiochemical purity) and evaluated in vitro and in vivo as an agent for targeting folate-receptor-positive cells. [99mTc]Tc(CO)3DTPA-folate experienced high, folate-receptor-specific uptake in human KB tumor cells. Intravenous administration of [99mTc]Tc(CO)3DTPA-folate to athymic mice bearing KB cell tumor xenografts resulted in 99mTc tumor uptake of 1.8 ± 0.5 and 3.3 ± 0.2%ID/g (n = 3) at 30 minutes and 4 hours post-injection, respectively. Tumor uptake was reduced when folic acid was co-administered with the intravenous [99mTc]Tc(CO)3DTPA-folate, consistent with radiopharmaceutical localization being mediated by the folate receptor.

Original languageEnglish (US)
Pages (from-to)569-573
Number of pages5
JournalNuclear Medicine and Biology
Volume29
Issue number5
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Radiopharmaceuticals
Folic Acid
Carbon Monoxide
KB Cells
Neoplasms
technetium Tc 99m tricarbonyl DTPA-folate
Heterografts
Nude Mice
Intravenous Administration
Heating
High Pressure Liquid Chromatography
Injections

Keywords

  • Tc(CO)-DTPA-folate
  • Folate binding protein
  • Technetium carbonyl
  • Tumor-targeting

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Synthesis and evaluation of 99mTc(CO)3-DTPA-folate as a folate-receptor-targeted radiopharmaceutical. / Trump, David P.; Mathias, Carla J.; Yang, Zhenfan; Low, Philip S.; Marmion, Mary; Green, Mark.

In: Nuclear Medicine and Biology, Vol. 29, No. 5, 2002, p. 569-573.

Research output: Contribution to journalArticle

Trump, David P. ; Mathias, Carla J. ; Yang, Zhenfan ; Low, Philip S. ; Marmion, Mary ; Green, Mark. / Synthesis and evaluation of 99mTc(CO)3-DTPA-folate as a folate-receptor-targeted radiopharmaceutical. In: Nuclear Medicine and Biology. 2002 ; Vol. 29, No. 5. pp. 569-573.
@article{3e1125034e274d6ca1bdab7c47d0a64a,
title = "Synthesis and evaluation of 99mTc(CO)3-DTPA-folate as a folate-receptor-targeted radiopharmaceutical",
abstract = "A folate-receptor-targeted 99mTc-radiopharmaceutical, [99mTc]Tc(CO)3DTPA-folate, was prepared by heating [99mTc]Tc(CO)3(H2O)3+ in an aqueous solution of the previously reported DTPA-folate conjugate. The radiotracer was HPLC purified (> 98{\%} radiochemical purity) and evaluated in vitro and in vivo as an agent for targeting folate-receptor-positive cells. [99mTc]Tc(CO)3DTPA-folate experienced high, folate-receptor-specific uptake in human KB tumor cells. Intravenous administration of [99mTc]Tc(CO)3DTPA-folate to athymic mice bearing KB cell tumor xenografts resulted in 99mTc tumor uptake of 1.8 ± 0.5 and 3.3 ± 0.2{\%}ID/g (n = 3) at 30 minutes and 4 hours post-injection, respectively. Tumor uptake was reduced when folic acid was co-administered with the intravenous [99mTc]Tc(CO)3DTPA-folate, consistent with radiopharmaceutical localization being mediated by the folate receptor.",
keywords = "Tc(CO)-DTPA-folate, Folate binding protein, Technetium carbonyl, Tumor-targeting",
author = "Trump, {David P.} and Mathias, {Carla J.} and Zhenfan Yang and Low, {Philip S.} and Mary Marmion and Mark Green",
year = "2002",
doi = "10.1016/S0969-8051(02)00310-4",
language = "English (US)",
volume = "29",
pages = "569--573",
journal = "Nuclear Medicine and Biology",
issn = "0969-8051",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Synthesis and evaluation of 99mTc(CO)3-DTPA-folate as a folate-receptor-targeted radiopharmaceutical

AU - Trump, David P.

AU - Mathias, Carla J.

AU - Yang, Zhenfan

AU - Low, Philip S.

AU - Marmion, Mary

AU - Green, Mark

PY - 2002

Y1 - 2002

N2 - A folate-receptor-targeted 99mTc-radiopharmaceutical, [99mTc]Tc(CO)3DTPA-folate, was prepared by heating [99mTc]Tc(CO)3(H2O)3+ in an aqueous solution of the previously reported DTPA-folate conjugate. The radiotracer was HPLC purified (> 98% radiochemical purity) and evaluated in vitro and in vivo as an agent for targeting folate-receptor-positive cells. [99mTc]Tc(CO)3DTPA-folate experienced high, folate-receptor-specific uptake in human KB tumor cells. Intravenous administration of [99mTc]Tc(CO)3DTPA-folate to athymic mice bearing KB cell tumor xenografts resulted in 99mTc tumor uptake of 1.8 ± 0.5 and 3.3 ± 0.2%ID/g (n = 3) at 30 minutes and 4 hours post-injection, respectively. Tumor uptake was reduced when folic acid was co-administered with the intravenous [99mTc]Tc(CO)3DTPA-folate, consistent with radiopharmaceutical localization being mediated by the folate receptor.

AB - A folate-receptor-targeted 99mTc-radiopharmaceutical, [99mTc]Tc(CO)3DTPA-folate, was prepared by heating [99mTc]Tc(CO)3(H2O)3+ in an aqueous solution of the previously reported DTPA-folate conjugate. The radiotracer was HPLC purified (> 98% radiochemical purity) and evaluated in vitro and in vivo as an agent for targeting folate-receptor-positive cells. [99mTc]Tc(CO)3DTPA-folate experienced high, folate-receptor-specific uptake in human KB tumor cells. Intravenous administration of [99mTc]Tc(CO)3DTPA-folate to athymic mice bearing KB cell tumor xenografts resulted in 99mTc tumor uptake of 1.8 ± 0.5 and 3.3 ± 0.2%ID/g (n = 3) at 30 minutes and 4 hours post-injection, respectively. Tumor uptake was reduced when folic acid was co-administered with the intravenous [99mTc]Tc(CO)3DTPA-folate, consistent with radiopharmaceutical localization being mediated by the folate receptor.

KW - Tc(CO)-DTPA-folate

KW - Folate binding protein

KW - Technetium carbonyl

KW - Tumor-targeting

UR - http://www.scopus.com/inward/record.url?scp=0035999173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035999173&partnerID=8YFLogxK

U2 - 10.1016/S0969-8051(02)00310-4

DO - 10.1016/S0969-8051(02)00310-4

M3 - Article

C2 - 12088727

AN - SCOPUS:0035999173

VL - 29

SP - 569

EP - 573

JO - Nuclear Medicine and Biology

JF - Nuclear Medicine and Biology

SN - 0969-8051

IS - 5

ER -